Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 221-224

  Bostom, Andrew G ^a,b   Gohh, Reginald Y ^c   Liaugaudas, Gintaras ^a   Beaulieu, Andrew J ^c   Han, Haewook ^b   Jacques, Paul F ^b   Dworkin, Lance ^c   Rosenberg, Irwin H ^b   Selhub, Jacob ^b  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b TUFTS UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Arteriosclerosis; Folate; Homocysteine; Renal disease

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CEREAL; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; FLOUR; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

CORONARY DISEASE; FASTING; FEMALE; FLOUR; FOLIC ACID; FOOD, FORTIFIED; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; VITAMIN B 12;

EID: 0033014191     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00023-4     Document Type: Article

References (20)

1. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. New Engl J Med. 337:1997;230-236.
2. Massy Z.A., Chadefaux-Vekemans B., Chevalier A., Bader C.A., Drueke T.B., Legendre C. et al. Hyperhomocysteinemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant. 9:1994;1103-1108.
3. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc. 270:1993;2693-2698.
4. Pancharuniti N., Lewis C.A., Sauberlich H.E., Perkins L.L., Go R.C., Alvarez J.O. et al. Plasma homocysteine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 59:1994;940-948.
5. Ducloux D., Fournier V., Rebibou J.M., Bresson-Vautrin C., Gibey R., Chalopin J.M. Hyperhomocysteinemia in renal transplant recipients with and without cyclosporine. Clin Nephrol. 19:1998;232-235.
6. Folic acid content of some grain foods is mandated by FDA. The Wall Street Journal. 5 January:1998.
7. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist. 61:1996;8781-8797.
8. Bostom A.G., Shemin D., Lapane K.L., Hume A.L., Yoburn D., Nadeau M.R. et al. High-dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 49:1996;147-152.
9. Chauveau P., Chadefaux B., Coude M., Aupetit J., Kamoun P., Jungers P. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab. 22:1996;106-109.
10. Bostom A.G., Gohh R.Y., Beaulieu A.J., Nadeau M.R., Hume A.L., Jacques P.F. et al. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med. 127:1997;1089-1092.
11. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M. et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc. 277:1997;1775-1781.
12. SAS Version 6.08. 1991;SAS Institute Inc, Cary, NC.
13. Malinow M.R., Nieto F.J., Kruger W.D., Duell P.B., Hess D.L., Gluckman R.A. et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrhydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol. 17:1997;1157-1162.
14. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J. 316:1998;894-898.
15. Malinow M.R., Duell P.B., Hess D.L., Anderson P.H., Kruger W.D., Phillipson B.E. et al. Reduction of plasma homocysteine levels by breakfast cereals fortified with folic acid in patients with coronary heart disease. New Engl J Med. 338:1998;1009-1015.
16. Schorah C.J., Devitt H., Lucock M., Dowell A.C. The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur J Clin Nutr. 52:1998;407-411.
17. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. Impact of folic acid fortification on plasma folate and total homocysteine concentrations in middle-aged and other adults from the Framingham Study. N Engl J Med 1999; in press.
18. Bostom A.G., Shemin D., Verhoef P., Nadeau M.R., Jacques P.F., Selhub J. et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol. 17:1997;2554-2558.
19. Jungers P., Chauveau P., Bandin O., Chadefaux B., Aupetit J., Labrunie M. et al. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab. 23:1997;170-173.
20. Moustapha A., Naso A., Nahlawi M., Gupta A., Arheart K.L., Jacobsen D.W. et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation. 97:1998;138-141.